scholarly article | Q13442814 |
P50 | author | Sumayya Haffejee | Q114401285 |
Marietjie Venter | Q39062606 | ||
Michelle J. Groome | Q40130392 | ||
Cheryl Cohen | Q55762440 | ||
Shabir A. Madhi | Q56065756 | ||
Marthi Pretorius | Q57453583 | ||
Stefano Tempia | Q57874460 | ||
Kathleen Kahn | Q60500113 | ||
Anne von Gottberg | Q60557680 | ||
Sibongile Walaza | Q61196380 | ||
Nicole Wolter | Q79438003 | ||
Halima Dawood | Q88140530 | ||
Meera Chhagan | Q92620576 | ||
Jocelyn Moyes | Q114401271 | ||
Fathima Naby | Q114401277 | ||
P2093 | author name string | Adam L Cohen | |
South African Severe Acute Respiratory Illness Surveillance Group | |||
P2860 | cites work | Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis | Q29619821 |
Evolutionary dynamics of 2009 pandemic influenza A virus subtype H1N1 in South Africa during 2009-2010. | Q30423864 | ||
The burden of respiratory syncytial virus infection in young children | Q34938343 | ||
An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children | Q35595950 | ||
Concurrent serious bacterial infections in 912 infants and children hospitalized for treatment of respiratory syncytial virus lower respiratory tract infection | Q35688314 | ||
Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics | Q36093377 | ||
Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance | Q37388667 | ||
Risk of concurrent bacterial infection in preterm infants hospitalized due to respiratory syncytial virus infection | Q37860339 | ||
Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children | Q39542957 | ||
Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus infection | Q39656649 | ||
Respiratory viruses seasonality in children under five years of age in Buenos Aires, Argentina: a five-year analysis | Q39693354 | ||
Surveillance for Respiratory Syncytial Virus in Infants Hospitalized for Acute Lower Respiratory Infection in Chile (1989 to 2000) | Q40133171 | ||
Risk factors for severe respiratory syncytial virus lower respiratory tract infection | Q40412523 | ||
Enhanced adherence of Streptococcus pneumoniae to human epithelial cells infected with respiratory syncytial virus | Q40563862 | ||
Bacteraemia and antibiotic use in respiratory syncytial virus infections | Q41862035 | ||
Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. | Q42413001 | ||
Pulmonary and systemic bacterial co-infections in severe RSV bronchiolitis | Q43099663 | ||
Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children | Q45416972 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | South Africa | Q258 |
hospitalization | Q3140971 | ||
P304 | page(s) | S217-26 | |
P577 | publication date | 2013-12-01 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011. | |
P478 | volume | 208 Suppl 3 |
Q35819384 | Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa |
Q33908117 | Attributable Fraction of Influenza Virus Detection to Mild and Severe Respiratory Illnesses in HIV-Infected and HIV-Uninfected Patients, South Africa, 2012-2016. |
Q58493922 | Burden and Epidemiology of Influenza- and Respiratory Syncytial Virus-Associated Severe Acute Respiratory Illness Hospitalization in Madagascar, 2011-2016 |
Q89763245 | Burden and seasonality of medically attended influenza like illness (ILI) in Ethiopia, 2012 to 2017 |
Q91610246 | Case fatality rate and viral aetiologies of acute respiratory tract infections in HIV positive and negative people in Africa: The VARIAFRICA-HIV systematic review and meta-analysis |
Q56888546 | Contemporaneous data on the prevalence of Human Respiratory Syncytial Virus infection in people with acute respiratory tract infections in Africa (2000-2017) |
Q35229634 | Deaths associated with respiratory syncytial and influenza viruses among persons ≥5 years of age in HIV-prevalent area, South Africa, 1998-2009(1). |
Q36029731 | Detection of Multiple Respiratory Viruses Associated With Mortality and Severity of Illness in Children |
Q30238589 | Epidemiology of Viral Pneumonia |
Q34772743 | Epidemiology of viral-associated acute lower respiratory tract infection among children <5 years of age in a high HIV prevalence setting, South Africa, 2009-2012 |
Q33884440 | Estimating influenza and respiratory syncytial virus-associated mortality in Western Kenya using health and demographic surveillance system data, 2007-2013 |
Q40040542 | Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series |
Q42211643 | High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia |
Q34057989 | Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures. |
Q34781034 | Hospitalizations associated with influenza and respiratory syncytial virus among patients attending a network of private hospitals in South Africa, 2007-2012. |
Q40043100 | Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines |
Q34264615 | Immunity to RSV in Early-Life. |
Q45326215 | In- and Out-of-hospital Mortality Associated with Seasonal and Pandemic Influenza and Respiratory Syncytial Virus in South Africa, 2009-2013. |
Q38594067 | Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics |
Q30359417 | Mortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children <5 years of age in a high HIV prevalence setting--South Africa, 1998-2009. |
Q59358634 | Prevalence of human respiratory syncytial virus infection in people with acute respiratory tract infections in Africa: A systematic review and meta-analysis |
Q47150385 | Respiratory syncytial and influenza viruses in children under 2 years old with severe acute respiratory infection (SARI) in Maputo, 2015. |
Q30244591 | Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis |
Q38693999 | Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting |
Q33892605 | Respiratory syncytial virus infections in infants affected by primary immunodeficiency. |
Q40693894 | Respiratory viruses in young South African children with acute lower respiratory infections and interactions with HIV. |
Q33629197 | Risk Factors for Influenza-Associated Severe Acute Respiratory Illness Hospitalization in South Africa, 2012-2015 |
Q26774885 | Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis |
Q40419642 | Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection With Viral Coinfection in HIV-Uninfected Children |
Q33737024 | The Enduring Challenge of Determining Pneumonia Etiology in Children: Considerations for Future Research Priorities |
Q63866059 | The Fraction of Rhinovirus Detections Attributable to Mild and Severe Respiratory Illness in a Setting of High Human Immunodeficiency Virus Prevalence, South Africa, 2013–2015 |
Q47569006 | The effects of the attributable fraction and the duration of symptoms on burden estimates of influenza-associated respiratory illnesses in a high HIV prevalence setting, South Africa, 2013-2015. |
Q64125901 | The impact of HIV exposure on respiratory syncytial virus-associated severe respiratory illness in South African infants, 2011-2016 |
Q56567257 | The role of HIV in influenza- and respiratory syncytial virus-associated hospitalizations in South African children, 2011-2016 |
Q33801297 | Tuberculosis and pneumonia in HIV-infected children: an overview |
Q38868960 | Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality? |
Search more.